BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22000981)

  • 21. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
    Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
    Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low vegetable intake is strongly associated with venous thromboembolism in Thai population.
    Bhoopat L; Rojnuckarin P; Hiransuthikul N; Intragumtornchai T
    Blood Coagul Fibrinolysis; 2010 Dec; 21(8):758-63. PubMed ID: 20885294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prophylactic recombinant erythropoietin therapy and thalidomide are predictors of venous thromboembolism in patients with multiple myeloma: limited effectiveness of thromboprophylaxis.
    Anaissie EJ; Coleman EA; Goodwin JA; Kennedy RL; Lockhart KD; Stewart CB; Coon SK; Bailey C; Barlogie B
    Cancer; 2012 Jan; 118(2):549-57. PubMed ID: 21720994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of venous thromboembolism in newly diagnosed patients treated for lymphoid malignancies: validation of the Khorana Risk Score.
    Rupa-Matysek J; Gil L; Kaźmierczak M; Barańska M; Komarnicki M
    Med Oncol; 2017 Dec; 35(1):5. PubMed ID: 29209847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Venous-thromboembolism and associated health care utilization in elderly patients with diffuse large B cell lymphoma.
    Gangaraju R; Davis ES; Bhatia S; Kenzik KM
    Cancer; 2022 Jun; 128(12):2348-2357. PubMed ID: 35363373
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
    Hanson SJ; Punzalan RC; Greenup RA; Liu H; Sato TT; Havens PL
    J Trauma; 2010 Jan; 68(1):52-6. PubMed ID: 20065757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The incidence, risk factors, and prognosis of recurrent venous thromboembolism (VTE) in patients with advanced solid cancers receiving anticoagulation therapy after the diagnosis of index VTE.
    Yhim HY; Jang MJ; Kwak JY; Yim CY; Choi WI; Lee YC; Lee JO; Lee KW; Bang SM; Kim SH; Kim YK; Chang HJ; Oh D;
    Thromb Res; 2013 Apr; 131(4):e133-40. PubMed ID: 23399441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venous thromboembolism in adults treated for acute lymphoblastic leukaemia: Effect of fresh frozen plasma supplementation.
    Lauw MN; Van der Holt B; Middeldorp S; Meijers JC; Cornelissen JJ; Biemond BJ
    Thromb Haemost; 2013 Apr; 109(4):633-42. PubMed ID: 23364346
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of residual risk factors for the development of venous thromboembolism in medical inpatients receiving subcutaneous heparin therapy for prophylaxis.
    Kato S; Shimada YJ; Friedmann P; Kashan G; Husk G; Bergmann SR
    Coron Artery Dis; 2012 Jun; 23(4):294-7. PubMed ID: 22421548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of venous thromboembolism in patients with overt hyperthyroidism: a retrospective multicentre cohort study.
    Kootte RS; Stuijver DJ; Dekkers OM; van Zaane B; Fliers E; Cannegieter SC; Gerdes VE
    Thromb Haemost; 2012 Mar; 107(3):417-22. PubMed ID: 22234657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
    Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
    Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
    Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
    Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor grade is associated with venous thromboembolism in patients with cancer: results from the Vienna Cancer and Thrombosis Study.
    Ahlbrecht J; Dickmann B; Ay C; Dunkler D; Thaler J; Schmidinger M; Quehenberger P; Haitel A; Zielinski C; Pabinger I
    J Clin Oncol; 2012 Nov; 30(31):3870-5. PubMed ID: 23008313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Venous thromboembolism in ANCA-associated vasculitis--incidence and risk factors.
    Stassen PM; Derks RP; Kallenberg CG; Stegeman CA
    Rheumatology (Oxford); 2008 Apr; 47(4):530-4. PubMed ID: 18356178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoma and venous thromboembolism: influence on mortality.
    Mahajan A; Wun T; Chew H; White RH
    Thromb Res; 2014 May; 133 Suppl 2():S23-8. PubMed ID: 24862141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency, demographics and risk (according to tumour type or site) of cancer-associated thrombosis among patients seen at outpatient DVT clinics.
    Paneesha S; McManus A; Arya R; Scriven N; Farren T; Nokes T; Bacon S; Nieland A; Cooper D; Smith H; O'Shaughnessy D; Rose P;
    Thromb Haemost; 2010 Feb; 103(2):338-43. PubMed ID: 20024496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Central nervous system involvement in diffuse large B-cell lymphoma.
    Yamamoto W; Tomita N; Watanabe R; Hattori Y; Nakajima Y; Hyo R; Hashimoto C; Motomura S; Ishigatsubo Y
    Eur J Haematol; 2010 Jul; 85(1):6-10. PubMed ID: 20236301
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low absolute lymphocyte count and addition of rituximab confer high risk for interstitial pneumonia in patients with diffuse large B-cell lymphoma.
    Huang YC; Liu CJ; Liu CY; Pai JT; Hong YC; Teng HW; Hsiao LT; Chao TC; Gau JP; Liu JH; Hsu HC; Chiou TJ; Chen PM; Yu YB; Tzeng CH
    Ann Hematol; 2011 Oct; 90(10):1145-51. PubMed ID: 21647583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.
    Kakkar AK; Cohen AT; Tapson VF; Bergmann JF; Goldhaber SZ; Deslandes B; Huang W; Anderson FA;
    Ann Surg; 2010 Feb; 251(2):330-8. PubMed ID: 20054273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.